Causal Mediation Analysis Leveraging Multiple Types of Summary
  Statistics Data by Park, Yongjin et al.
Causal Mediation Analysis Leveraging Multiple Types of Summary Statistics Data
Yongjin Park,1, 2 Abhishek Sarkar,3 Khoi Nguyen,1, 2 and Manolis Kellis1, 2
1Computer Science and Artificial Intelligence Laboratory,
Massachusetts Institute of Technology, Cambridge, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Department of Human Genetics, University of Chicago, Chicago, IL
Summary statistics of genome-wide association studies (GWAS) teach causal relationship between
millions of genetic markers and tens and thousands of phenotypes. However, underlying biological
mechanisms are yet to be elucidated. We can achieve necessary interpretation of GWAS in a causal
mediation framework, looking to establish a sparse set of mediators between genetic and downstream
variables, but there are several challenges. Unlike existing methods rely on strong and unrealistic
assumptions, we tackle practical challenges within a principled summary-based causal inference
framework. We analyzed the proposed methods in extensive simulations generated from real-world
genetic data. We demonstrated only our approach can accurately redeem causal genes, even without
knowing actual individual-level data, despite the presence of competing non-causal trails.
I. INTRODUCTION
Genome-wide association studies (GWAS) identify sta-
tistically significant correlations between genetic and phe-
notypic variables. In the era of Biobank GWAS, pheno-
types can be virtually any variables measurable across
millions of individuals in the database, of which exam-
ples include diagnosis codes, routine laboratory test re-
sults, family history of complex disorders, and even socio-
economical status.
Significant signals of well-executed GWAS implicate
unidirectional causal relationship from the tagged genomic
variants to phenotypes, not the other way. In biological
information cascade, using GWAS, we can establish links
between the very first (genetics) and the last (pheno-
types) layers, and we normally expect the effect sizes are
typically minuscule; and necessary statistical significance
can be achieved in studies involving at least hundreds of
thousands of individuals. Nonetheless, a large number of
GWAS summary statistics data are already made pub-
licly available. Geneticists have already uncovered more
than 24k unique associations between single nucleotide
polymorphism (SNP) markers and complex phenotypes
[16].
However, a fundamental limitation of GWAS remains
in its lack of interpretability. As it can only suggest po-
sitions (SNPs) in the human genome without providing
any mechanistic insights into how these loci exert their
action. Unlike conventional differential gene expression
analysis, nearly 90% of significant genetic loci fall non-
coding regions [6]; therefore, even knowing a target gene
and relevant regulatory context is already a big challenge
in most post-GWAS analysis. Obviously, by characteriza-
tion of gene names and related pathways beyond a set of
genomic locations, we can begin to understand biological
mechanisms to find a suitable entry point of therapeutics.
We recognize interpretation of GWAS can be improved
by solving a series of causal mediation problems. The
basic idea is to jointly analyze GWAS data with other
types of genetic association statistics that connect genetic
variants (SNPs) to endo-phenotypes located in the mid-
dle between genetic and phenotypic layers. We transfer
knowledge of intermediate genetic regulatory mechanisms
to marginalized GWAS summary data [4].
GWAS: SNP→
unknown︷︸︸︷· · · → disease
eQTL: SNP→ gene
mediation: SNP→ gene → disease
Of many possible types of endo-phenotypes, we focus
on finding a set of causal genes that mediate between
initiating SNPs and target phenotypes, such as complex
diseases. We leverage the knowledge of existing eQTL
(expression qualitative trait locus) summary statistics. In
eQTL summary statistics data, we compile effect sizes
of genetic associations of nearly 20k genes with common
genetic variants (SNPs). On each gene, approximately
1k-10k neighboring SNPs are typically tested within a ±
1 megabase window (cis-eQTLs). Since we only investi-
gate mediation of cis-regulatory mechanisms, mediation
analysis can be conducted within a segment of genome.
We break down the whole genome into 1,703 independent
blocks [2].
In “causal” mediation analysis, we emphasize that cor-
relation is never causality because observed gene-disease
association / correlation signals can be interpreted as
many different causal mechanisms (Fig.1). Of them, we
are particularly interesting in redeeming the mediation
effect; only the mediating gene can causally alter predis-
position of the disease.
a. Our contributions In this work, we contribute a
general causal inference method for multivariate medi-
ation analysis, leveraging two types of summary statis-
tics data–one linking instrumental variables (genetics)
to outcome variables (phenotypes) and the other link-
ing instrumental variables with mediator variables (endo-
phenotypes; genes).
First, we carefully examine the underlying mediation
problem in details, and reveal that a subtle difference
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FIG. 1: Association between gene and disease can be inter-
preted in multiple ways.
can substantially alter identifiability of the underlying
statistical problem. We claim that practical issues, such
as incomplete knowledge of mediation, polygenic bias, and
uncharacterized confounding effects, should be carefully
controlled; otherwise, association-based methods may pile
up wrong interpretation of GWAS results.
Second, to our knowledge, this work[26] is the first at-
tempt in summary-based mediation analysis to include
and test multiple mediation variables within a single
Bayesian framework. Our formalism might be summary-
based translation of the existing proposal for fully ob-
served individual-level data [23], but we address practical
issues hidden underneath the observed summary statis-
tics.
Third, our approach is built on a principled multivariate
model, which takes into accounts of inherent dependency
structure between a large number of genetic variants.
We resolve the unavoidable issue of high-dimensional
collinearity using sparse Bayesian variable selection [18],
and demonstrate that our Bayesian approach yields supe-
rior performance in relevant simulations.
Fourth, we propose novel, yet simple, operational steps
generally applicable to summary-based causal inference
problems. We solve a long-standing problem of confounder
correction in genetics data, not relying on unrealistic
simplifications and assumptions.
b. Related work Mendelian Randomization (MR) [13,
21] resolves causal directions by using genetic variants as
instrumental variables (IV) in causal inference analysis.
However, MR assumes that entire proportion of causal
effects in the genetic locus on the phenotype are mediated
by the measured intermediate phenotype (e.g. expression
of a given gene in the given cell type) [5, 21], which asserts
there is no other causal trails exist, and more importantly
most MR method only works on a few IV variants.
Transcriptome-wide association studies (TWAS) aggre-
gates information of multiple variants to find genes whose
regulatory variants have correlated effect sizes for both
gene expression and downstream phenotypes [8, 9, 17].
However, TWAS methods are fundamentally limited be-
cause they cannot distinguish between causal mediation,
pleiotropy, linkage between causal variants, and reverse
causation, which could lead to inflated false positives.
II. CAUSAL MEDIATION ANALYSIS
A. A generative model of phenotypic variability
mediated by gene expressions
We model a phenotype vector y of n individuals as
a function of genotype information measured across p
common variants (SNPs).
y ∼ Xθ + ,  ∼ N (0, σ2I) (1)
with the multivariate effect size θ. We assume irreducible
isotropic noise  fluctuates with some variance σ2. For
simplicity, we assume the GWAS trait is quantitative, yi ∈
R and the genotype matrix X is column-wise standardized
with mean zero and unit standard deviation.
Conventional definition of GWAS statistics refers a uni-
variate effect size (a regression slope of a simple regression
(or log-odds ratio) in case-control studies) measured on
each genetic variant. In summary data, we have a vector
of p summary statistics, effect size θˆj and corresponding
variance σˆ2j for each SNP j ∈ [p].
θˆj =
x>j y
x>j xj
and σˆ2j =
(y − xj θˆj)>(y − xj θˆj)
nx>j xj
. (2)
However, due to linkage disequilibrium (LD; correlations
between neighboring SNPs), an effect size measured on
each single variant contains contributions from the neigh-
boring SNPs.
Likewise, expression profiles of K genes are generated
by the same type of models on the shared genotype matrix
X. For each gene k ∈ [K], we define a generative model
of gene expression mk:
mk = Xαk + δk, δk ∼ N
(
0, τ2k I
)
(3)
where multivariate eQTL effect size vector αk exerts an
action on each gene k, but there is a measurement error
δ with non-genetic variance τk.
B. Two types of mediation models
Before we present methods and algorithms, we digress
to dissect identifiability issues with intuitive examples.
Total genetic effect Xθ on the phenotypic variation
(Eq.1) decomposes into two components, mediated from
the causal genes Xαkβk with mediation effect size βk and
unmediated effects Xγ with some coefficients γ. In other
words, Xθ = X(
∑
k αkβk + γ).
Overall, this generative scheme (Fig.2a) is generally
acceptable to most of genetics and epidemiology research
community, but we demonstrate a subtle, yet critical dif-
ference about when we actually measure the mediation
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FIG. 2: (a) A graphical model for the full generative scheme
with K genes. X: genotype matrix; M (unfilled): genuine
mediation effect; M (filled): observed mediation variable; Y :
phenotype measurement; U : unmeasured confounding variable;
α: eQTL effect size; β: mediation effect size; γ: unmediated
effect size; δ: non-genetic components in gene expression
variation; : non-genetic components in phenotypic variation.
(b) The symmetric variance model (see the text). (c) The
asymmetric variance model (see the text).
profiles with non-genetic stochasticity δ (Fig.2b versus c)
can make impact on identifiability. In the former model
(b), we assume that the non-genetic components δ are
mostly attributable to technical covariates, and estimable
through control genes in eQTL analysis [7, 20], whereas
in the latter case (c), non-genetic signals δ first biologi-
cally incorporate and become transmitted to downstream
phenotypic variation. We term them symmetric and
asymmetric variance models, respectively, as they result
in different variance structures in the following model
identification steps.
a. Symmetric variance model For intuitive explana-
tion, without loss of generality, suppose we only have a
single gene and a single genetic variant in the model. If
we assume stochasticity was infused after the mediation,
we generate the phenotype by
y = xαβ + xγ + ,
but we only observe gene expression with stochasticity,
m = xα+δ with δ ∼ N (0, τ2I). However, we can obtain
unbiased estimation of the eQTL effect, µ ≡ xα, and use
this to test the mediation of this gene expression.
We set up two regression problems: (1) y ∼ µβ (for
the mediated effect) and (2) y ∼ xθ (for the direct /
unmediated effect). Straightforward algebraic derivation
characterize the distribution of estimate βˆ as
βˆ ∼ N (β + α−1γ, σ2n−1α−2) ,
and the estimated mediated effect size follows
αˆβˆ ∼ N
(
αβ + γ,
σ2
n
)
.
This coincides with the same distribution of direct
(marginal) GWAS statistic:
θˆ =
x>y
x>x
∼ N
(
αβ + γ,
σ2
n
)
.
Remark : Not only we have the same mean, but also the
variance in both causal trails is symmetric. Two causal
trails are non-identifiable [1, 9], unless we apply a suitable
causal inference method.
b. Asymmetric variance model However, if we as-
sume stochasticity was infused before the mediation, we
generate the phenotype by
y = (xα+ δ)β + xγ + ,
and it yields asymmetric variance models. The effect size
distribution of the estimated mediated trail follows
αˆβˆ ∼ N
(
αβ + γ,
β2τ2 + σ2
n
)
since the gene-level association effect size follows
βˆ ∼ N (β + α−1γ, (β2τ2 + σ2)n−1α−2) .
On the other hand, direct genetic association statistic
takes a rather different form of distribution:
θˆ =
x>y
x>x
∼ N
(
αβ + γ,
τ2 + σ2
n
)
.
Remark: These two distributions are distinguishable by
the asymmetry of variance. Whenever there is non-zero
mediation effects, β 6= 0, we will have larger fluctuation
of the mediated effect, but in standard error estimation
we will omit β2τ2/n and under-estimate the variance as
σ2/n. Moreover, if gene expression heritability is lower,
meaning higher τ2, the identification problem becomes
easier. This is somewhat paradoxical.
MR community [3, 10] has adopted this type of genera-
tive models in their simulation studies, but it appears that
we may not need strong causal assumptions to identify
mediation effects under this type of model since we can
identify causal effects by brute-force model estimation.
4C. Practical issues in mediation analysis
a. Strongest correlation is not necessarily causation
First of all, we assume true data generation scheme is
much closer to the symmetric variance model than the
asymmetric variance model. Although we have inves-
tigated the asymmetric variance assumption and our
method excels, we concluded that performance under
the asymmetric model largely depends on statistical esti-
mation accuracy, rather than causal inference.
b. Missing mediation problem All genes are heritable
by definition, but only some of them are measurable in
given eQTL data. It may stem from the lack of statistical
power, or true genetic variation of expression profiles may
be conditional with respect to a certain cellular context.
Moreover, it is not difficult to imagine that a causal gene
can be included in the missing component of mediation
effect. In that case, another non-causal gene correlated
with the causal one can easily lead to a false conclusion.
c. Pleiotropic and polygenic bias The missing medi-
ation problem can be exacerbated when there is substan-
tial amount of unmediated genetic, thus independently
pleiotropic, effect on the phenotype within LD (the sec-
ond one in Fig.1). It is commonly observed that this
pleiotropic effect is also highly polygenic, and creates lots
of confusions in causal mediation analysis.
III. CAUSAL INFERENCE ON SUMMARY
STATISTICS
a. A generative model of GWAS summary statistics
For simplicity, letting Sjj = σˆ
2
j + θˆ
2/n, we can redefine a
model equivalent to the previous one (Eq.1) with respect
to p-dimensional summary statistics, the regression with
summary statistics (RSS) model [25]:
θˆ ∼ N (SRS−1θ, SRS). (4)
Normally we have large enough sample size (n→∞), the
RSS model resorts to a fine-mapping model [11]. Genera-
tive scheme of a GWAS z-score vector, with each element
zj = θˆj/σˆj , is described by the reference LD matrix R
and true (multivariate) effect size vector θ.
z ∼ N (Rθ, σ2R). (5)
b. Reparameterized stochastic variational inference
The key challenge in fitting the RSS model is dealing
with the covariance matrix in the likelihood. To address
this challenge, we exploit the spectral decomposition of
the LD matrix [15]. With a singular value decomposition
(SVD) of the genotype matrix, such as
(n)−1/2X = UDV >, (6)
we deal with the LD matrix R = V D2V > and redefine a
new design matrix X˜ ≡ V > and a transformed outcome
vector y˜t ≡ V >S−1θˆt to obtain equivalent, but fully fac-
torized, multivariate Gaussian model:
yt ∼ N
(
D2X˜S−1θt, D2
)
.
Further, letting ηk ≡
∑p
j=1 VjkS
−1
j θj , we can rewrite the
transformed log-likelihood of the model for each eigen
component i:
lnP (y˜i|ηi) = −1
2
ln d2i −
1
2d2i
(y˜i − d2i ηi)2 −
1
2
ln(2pi).
We carry out stochastic variational inference [19] by simu-
lating stochasticity of η by simple reparameterization [14]
in the space of eigen vectors, not on the space of SNPs in
higher-dimensional space.
c. Derivation of summary-based mediation model We
present the full description of generative model,
y ∼ N
 ∑
k∈[K]
Xαkβk +Xγ, σ
2I
 ,
where the products of eQTL and mediation coefficients,
αkβk, capture mediation effects and γ denotes multivari-
ate effect sizes of the unmediated / direct pathway. We
can reformulate an equivalent model in terms of summary
z-scores:
zgwas ≈ (σ2n)−1/2X>y
∼ N
(√
n
σ
R
∑
k
αkβk +
√
n
σ
Rγ, R
)
.
Likewise, we can characterize distribution of each gene
k’s univariate z-score vector as:
zeQTLk ≈ n−1/2X>mk
∼ N
(
n−1/2Rαk, τ2R
)
.
Assuming that we tightly controlled measurement errors
in the eQTL data, i.e., τ2 → 0, we can substitute the
terms on the mediation effects of the GWAS model with
the z-scores of eQTL effects:
zgwas ∼ N
 ∑
k∈[K]
zeQTLk βk + n
−1/2Rγ, R
 . (7)
d. Identification of the unmediated “pleiotropic” ef-
fects Causality of this multivariate model can be made
by statistical inference as long as the unmediated effect
γ is estimable. To make it identifiable, previous methods
[1, 3] reduce the degree of freedom in the γ parameters
down to a mere intercept term. However, our simulation
suggests that sheer Bayesian inference on the full mul-
tivariate γ is indeed estimable if the GWAS and eQTL
summary statistics were generated by the asymmetric
variance model.
5On the other hand, in the symmetric variance model,
naive inference algorithm yields poor performance since
all the genuine mediation effects will be included in the
unmediated effect. We need to include an additional step
to construct features to characterize overall contribution
of the unmediated causal trails Xγ.
We first characterize independent components of genetic
variation across multiple genes and diseases. For one
GWAS and K eQTL z-scores, letting,
Z˜ ≡ (zgwas, zeQTL1 , . . . , zeQTLK ), (8)
we profile overall spectrum of variation by solving the
following sparse factorization problem:
E
[
Z˜
]
= n−1/2X>
( ∑
l∈factors
clω
>
l
)
. (9)
From this result, we obtain covariate matrix C, which
we can consider as projection of overall genetic variations
onto reference panel genotype space. We use this rich
vocabulary of C matrix to adjust potential unmediated
effects.
However, care should be taken. We exclude any column
vector cl if the corresponding ωl vector contains strong
non-zero elements in both GWAS and eQTL sides. For
instance, we call the l-th column is associated with gene
(or trait) k if posterior inclusion probability of ωkl greater
than 1/2. Our decision rule is largely compatible with the
widely accepted InSIDE (instrument strength indepen-
dent of direct effect) condition [3], but we actively search
for independent unmediated effects. On the selected L
unmediated effects cl, l ∈ [L], we can easily construct
z-scores, zunmedl = n
−1/2X>cl, we then resolve mediated
and unmediated effects in the following joint model:
zgwas ∼ N
 ∑
k∈[K]
zeQTLk βk +
∑
l∈[L]
zunmedl γl, R
 , (10)
where both β and γ follow the spike-slab prior [18].
e. Identification of hidden non-genetic confounding ef-
fects The sparse factorization result (Eq.9) still provides
a valuable resource in checking spurious correlations con-
founded by non-genetic factors (the third and fourth in
Fig1). However, there is a risk of over-correcting genuine
genetic correlations at the same time. We can sidestep
such a possibility by constructing a proxy data matrix
Z˜(0), on which we can warrant orthogonality with a geno-
type matrix. The idea is that we project our z-score ma-
trix Z˜ (Eq.8) onto independent LD blocks to adaptively
construct the proxy matrix for factorization analysis.
More precisely, we define non-genetic confounding effect
u between a gene expression m and phenotype vector y
as follows.
m = Xα+ u+ δ
y = Xαβ +Xγ + u+ .
Even though we have E
[
u>(Xα)
]
= 0 by definition, gene-
level correlation would have risk of including non-causal
effects:
m>y = (α>X>Xα)β︸ ︷︷ ︸
causal
+ u>(Xγ) + u>u︸ ︷︷ ︸
non-causal correlation
,
where we may expect the second term to vanish with large
n, but the third term persists.
We propose a simple operator to make intervention
only on the putative genetic components to yield a valid
proxy z-score matrix can selectively capture non-genetic
confounding effects.
As human LD patterns are close to a block-diagonal
covariance matrix, we can always find an independent LD
blockX(0) such that for all columns j ofX(0) is orthogonal
to the mediation effect, i.e., E
[
(X
(0)
j )
>(Xα)
]
= 0. Before
we carry out the factorization (Eq.9), we project the
combined z-score matrix of X onto some independent LD
block X(0):
Z˜(0) ← (X(0))>(X−>Z˜). (11)
As for the inverse step, we consider pseudo-inverse; by
SVD (Eq.6), X−> = UD−1V >. We perform factorization
on this Z˜(0),
E
[
Z˜(0)
]
= n−1/2(X(0))>CΩ (12)
and use n−1/2X>C to account for non-genetic correla-
tions.
Remark : We can justify this can effectively eliminate
genetic effects from summary statistics: Provided that
linear transformation of multivariate Gaussian distribu-
tion yields Gaussian distribution, we characterize the
mean vector and the covariance matrix after each step of
transformation. Without loss of generality, underlying n
individual-level target vector y has two components, Xα
and u. This induces the distribution of z-score vector:
z ∼ N (n−1/2X>(Xα+ u), n−1X>X). After the first
transformation, we have
X−>z ∼ N
(
n−1/2Xα+ n−1/2u, n−1I
)
.
Followed by the second transformation, we have
X>0 (X
−>z) ∼ N
(
n−1/2X>0 u, n
−1X>0 X0
)
,
because E
[
(x
(0)
j )
>(Xα)
]
= 0 for all j.
IV. EXPERIMENTS
a. Simulation based on real-world genotype matrix
To evaluate performance of our methods, we carried out
extensive and realistic sets of simulations. Unfortunately,
there is no labeled data for causal mediation analysis; the
6only gold standard would be a controlled experiment. We
might consider literature-based assessment, but for sys-
tematic comparison, we find simulation is more adequate.
We simulate eQTL and GWAS z-scores on selected
LD blocks [2] using standardized genotype matrix X,
sampled from the 1000 genomes reference panel [22], only
including individuals with European ancestry (n=502),
and restricting on the SNPs with minor allele frequency
(MAF) ≥ 0.05. This results in the matrix X (n× p) with
n = 502 and p = 5k-10k SNPs.
We have repeated our experiments using much larger
cohort, such as UK10K [12] samples (n=6,285), but results
were qualitatively identical; for brevity, we only report
the results of the 1000 genomes data.
We simulateK = 100 gene expression vectors {mk : k ∈
[K]}, and one phenotype vector y. For each simulation,
we provide the following parameters:
• X: a genotype matrix (column-wise standardized).
• g2g : proportion of gene expression variability ex-
plained by genetics; here, we fixed to 0.3.
• d: number of causal eQTL SNPs; variability of each
gene is determined by a linear combination of d
SNPs.
• u: in addition to genetic and unstructured noise
components, we have unknown random effect vector.
• h2m: proportion of phenotypic variability explained
by genetic effects mediated through causal genes.
• g2u: proportion of gene expression variability ex-
plained by the random effect u.
• h2u: proportion of phenotypic variability explained
by the random effect u.
Overall simulation steps proceed as follows.
1. Initially all genes are heritable. For each gene k ∈
[K], sample eQTL effect size αjk ∼ N
(
0, g2g/d
)
for
the causal SNP j on this gene k, but αjk = 0 for the
others. This easily ensures V[Xαk] = g2g . Genetic
components of this mediator is simply m
(g)
k ← Xαk.
2. We follow the asymmetric variance model. Sam-
ple mediation effect: βk ∼ N
(
0, h2m/m
)
for the
causal genes, otherwise βk = 0; then propagate the
mediated genetic effect to a genetic component of
phenotype: y(g) ←∑km(g)k βk.
3. For all gene k ∈ [K], we introduce structured ran-
dom effects, m
(u)
k ← uξk where ξk ∼ N (0, 1), and
rescale this vector such that V
[
m
(u)
k
]
= g2u.
4. We do the same on the phenotype, y(u) ← uξ0
where ξ0 ∼ N (0, 1), and rescale this vector such
that V
[
y(u)
]
= h2u.
5. For non-heritable (or missing) gene k, we eliminate
the genetic component, such as m
(g)
k ∼ N
(
0, g2g
)
.
Note that this may include a causal mediation gene.
6. The observed expression vector on each gene k is
mk ←m(g)k +m(u)k +δk where δk ∼ N
(
0, τ20 I
)
with
τ20 = 1− g2g − g2u.
7. We also observe the phenotype with the noise com-
ponents: y← y(g) + y(u) + , where  ∼ N (0, σ20)
with σ20 = 1− h2m − h2u.
b. Data For summary statistics-based methods, we
only provide these two types of z-scores calculated from
the simulated data, y,mk, not knowing the genetic part
of data, y(g),m
(g)
k .
c. CaMMEL methods We term our general method-
ology CaMMEL (causal multivariate mediation extended
by LD) as we test multiple mediation effects simultane-
ously, exploiting local LD structure. Here, we train the
CaMMEL model in three different ways and compared
them in the simulation studies:
• CaMMEL-naive: Brute-force variational Bayes in-
ference of the joint model with the multivariate
unmediated effect sizes (Eq.7).
• CaMMEL-factorization: A two-step inference algo-
rithm where we first characterize the unmediated
(direct) effects zunmed by fitting the factorization
model (Eq.9) and resolve the mediation effects in
the joint modeling (Eq.10).
• CaMMEL-projection: Another two-step inference
algorithm where we first project the combined z-
score matrix onto independent LD blocks (Eq.11),
then characterize the unmediated effects zunmed by
fitting the factorization model (Eq.12) to adjust non-
genetic / unmediated confounding effects. Here, we
adjust the GWAS z-score zgwas by subtracting out
the inferred zunmed and resolve the mediation effects
in the joint modeling only with the mediation terms
in Eq.10.
d. Competing methods As for the calculation of LD-
adjusted inverse-variance weighting (IVW) and summary-
based TWAS (sTWAS), we first perform SVD of the
reference genotype matrix (Eq.6), and this allows estima-
tion of the LD matrix by R = V D2V >. Since we know
z ∼ N (Rθ, R). We rotate the original distribution and
define another multivariate Gaussian random variable
η ≡ D−1V z ∼ N (DV >θ, I) for algebraic convenience.
Let ηeQTL ≡ D−1V zeQTL and ηgwas ≡ D−1V zgwas.
From these two vectors, we can write sTWAS test
statistics [17]:
T sTWAS = (ηeQTL)>ηgwas/
√
(ηeQTL)>ηeQTL.
Using mr ivw implemented in Mendelian
Randomization package [24], we can estimate IVW test
7statistics:
T IVW = βˆMLE max{σˆ, 1}/se(βˆ),
where βˆMLE, σˆ2 = arg maxN (ηgwas|ηeQTLβ, σ2I) with es-
timated standard error se(β). We could easily modify the
IVW method with different types of linear models, e.g.,
including an intercept term in the linear model to account
for directional pleiotropy, MR-Egger regression [1].
Lastly, we compare performance with the observed
TWAS (oTWAS), or differential expression analysis, cor-
relation between the observed phenotype y and noisy
observation of gene expression mk.
A. Experiments with strong polygenic bias and
missing causal genes
We carried out benchmark tests to evaluate robustness
of causal inference in the presence of strong polygenic
bias to the phenotype (Fig.3). We sampled 150 genes
(using actual gene locations in each LD block) and varied
the variance of polygenic bias (h2u ∈ {.2, .3, .4}). Of
the 150 genes, we excluded 50% of eQTL genes in the
observed statistics, which may or may not include two
causal genes. To simulate polygenic bias, we followed
a previously suggested simulation scheme [1], u = Xγ
where for each j ∈ [p] γj ∼ γ¯ +N (0, 10) with randomly
sampled direction γ¯ ∈ {+1,−1}. We report area under
precision recall curve (AUPRC) as metric as we have
much fewer causal genes (3) compared to the non-causal
ones (147). To be more exact, we only call prediction on
a gene is correct if and only if the gene is causal and the
sign of predicted effect size also matches with that of the
simulated effect.
When there is strong polygenic bias and a substantial
fraction of genes are missing, prediction accuracy (and
power) of most gene prediction methods can be severely
damaged. In human genetics data, unmediated polygenic-
ity is common observed across many different traits, and it
is almost impossible for us to obtain a full catalog of eQTL
genes. Interestingly, even though we did not include any
confounding effect on the mediators (genes), this type of
setting is enough to create confusion that univariate (gene-
by-gene) methods to make lots of false discoveries. Genes
are genetically dependent in LD and become conditionally
dependent given phenotype variables. Interestingly, the
MR-Egger method has been thought to handle a direc-
tional pleiotropy (polygenic bias) [1, 3], but we could only
find the worst performance in our simulations.
On the other hand, when the existing portion of un-
mediated effects are causally identified, our CaMMEL
methods robustly outperform other methods. Yet, naive
inference algorithm on the CaMMEL model shows far
worse performance because the parameters on the un-
mediated effect (γ) are much more adaptable to the data,
and yield far too conservative results.
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FIG. 3: In the experiments under the influence of directional
pleiotropy with 50% of genes missing, two of the CaMMEL
methods redeem genuine mediation trails with high accuracy.
B. Experiments with genes and phenotypes
confounded by non-genetic factors
Next, we conducted a new type of benchmark tests
where the genes and phenotype are confounded by non-
genetic effects. To set apart from the previous experi-
ments, we assumed genes are fully observed for simplicity;
by definition, we only considered that the non-genetic
confounders are independent of genetics. In most media-
tion analysis in genetics, we take for granted that such a
confounding effect were corrected out by pre-processing
steps. However, in practice, especially when there were
any sample overlap between eQTL and GWAS cohorts
(sharing controls), non-genetic correlations would always
exist with a high probability. As we collect more data from
biobank (where individuals are totally shared), finding a
non-genetic confounder across multiple traits is already a
crucial step in GWAS analysis.
In Fig.4, we show results with different levels of vari-
ability of the confounding effects on the mediator (the
row panels) and phenotype sides (the column panels).
As previously, we measure the performance in AUPRC
considering that only 1 gene is causal out of total 100
genes. When there is no confounding (the 1st row), all
the methods, except our CaMMEL with naive inference,
work similarly, achieving nearly optimal performance.
8confounding on Y = 0.1 confounding on Y = 0.3
confounding
on
M
=
0
confounding
on
M
=
0.1
confounding
on
M
=
0.3
0.05 0.10 0.15 0.20 0.05 0.10 0.15 0.20
0.2
0.4
0.6
0.8
1.0
0.2
0.4
0.6
0.8
1.0
0.2
0.4
0.6
0.8
1.0
proportion of variance explained by mediation
ar
ea
un
de
rp
re
ci
si
on
re
ca
ll
CaMMEL−proj
CaMMEL−fact
MR−Egger
CaMMEL−naive
oTWAS
IVW
sTWAS
#eQTL/gene: 2, #causal gene:1/100,
eQTL−gene distance ~ Exp(−1e−06* dist)
M
U
YX
M
U
YX
causal
non-causal
causal &
confounded
non-causal &
confounded
M
U
YX
M
U
YX
FIG. 4: Our method solves a long-standing problem in GWAS:
CaMMEL-proj removes non-causal confounding relationships
between mediators and outcome variables by projecting corre-
lation structure onto independent LD blocks to identify the
spurious ones.
However, we can clearly see the benefit of additional fac-
torization (CaMMEL-fact) and projection (CaMMEL-proj)
steps in causal inference, whenever two layers (of the
mediator and outcome variables) are confounded by un-
known variables, other than genetics. Most strikingly, our
results confirm that confounding effects become clearly
separable from genetic effects in the light of independent
LD blocks (CaMMEL-proj); and this can be done by a
simple algebraic operation.
V. DISCUSSION
The ultimate goal of mediation analysis in genetics is
to impute causality of GWAS, but previous gene-based
aggregated association methods only attempt to improve
statistical power apart from causal inference perspective.
In theory and experiments, we show that discoveries made
by a statistical method agnostic to causality can mis-
lead follow-up studies in practical settings. However, our
Bayesian approach to summary-based analysis truly seeks
to answer causal questions, explicitly constructing proxy-
variables to capture the unmediated and unwanted effects.
Moreover, our framework can robustly work against high-
dimensionality and collinearity of the parametric space,
naturally induced by human genetics.
In our software (available at https://ypark.github.
io/zqtl), we not only present a specialized routine for
mediation analysis, but also provide other commonly used
machine learning routines for summary statistics analysis.
We expect much more utility in future research.
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